These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3493569)

  • 21. Cyclosporine inhibits protein kinase C-dependent signals in human peripheral blood lymphocytes.
    McMillen MA; Schaefer HA; MacArthur JD; Adrian TA; Modlin IM
    J Surg Res; 1989 Apr; 46(4):292-5. PubMed ID: 2523008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mechanism of intercellular communication].
    Nishizuka Y
    Ryumachi; 1990 Dec; 30(6):449-50. PubMed ID: 1966061
    [No Abstract]   [Full Text] [Related]  

  • 24. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 26. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
    Schnaider T; Somogyi J; Csermely P; Szamel M
    Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1027-8. PubMed ID: 1989147
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporine action in blockade of cellular immune responses.
    Lorber MI
    Year Immunol; 1986; 2():279-88. PubMed ID: 3554824
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine sensitivity of human alloreactive T lymphocytes depends on the strength of the allogeneic stimulus.
    Kunkl A; Fenoglio D; Manca F; Caltabellotta M; Barocci S; Carozzi S; Valente U; Gessaga M; Celada F
    Transplant Proc; 1987 Feb; 19(1 Pt 1):262. PubMed ID: 2978901
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of L-selectin mRNA in Jurkat cells. Opposing influences of calcium- and protein kinase C-dependent signaling pathways.
    Kaldjian EP; Stoolman LM
    J Immunol; 1995 May; 154(9):4351-62. PubMed ID: 7536769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cyclosporine on canine lymphocyte activity.
    Payne JA; Herrod HG; Buice R
    J Clin Lab Immunol; 1986 Aug; 20(4):177-81. PubMed ID: 3531520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction.
    Smith DM; Bluestone JA; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1995 Feb; 27(1):395-7. PubMed ID: 7879035
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
    Rapecki S; Allen R
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cyclosporin-A-sensitive event in lymphocyte activation.
    Kay JE
    Ann Inst Pasteur Immunol; 1987; 138(4):622-5. PubMed ID: 3118906
    [No Abstract]   [Full Text] [Related]  

  • 35. The hepatitis C envelope 2 protein inhibits LFA-1-transduced protein kinase C signaling for T-lymphocyte migration.
    Volkov Y; Long A; Freeley M; Golden-Mason L; O'Farrelly C; Murphy A; Kelleher D
    Gastroenterology; 2006 Feb; 130(2):482-92. PubMed ID: 16472601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotactic peptide activation of human neutrophils and HL-60 cells. Pertussis toxin reveals correlation between inositol trisphosphate generation, calcium ion transients, and cellular activation.
    Krause KH; Schlegel W; Wollheim CB; Andersson T; Waldvogel FA; Lew PD
    J Clin Invest; 1985 Oct; 76(4):1348-54. PubMed ID: 3877077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenascin suppresses CD3-mediated T cell activation.
    Hibino S; Kato K; Kudoh S; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1998 Sep; 250(1):119-24. PubMed ID: 9735343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro.
    Taub DD; Turcovski-Corrales SM; Key ML; Longo DL; Murphy WJ
    J Immunol; 1996 Mar; 156(6):2095-2103. PubMed ID: 8690897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
    J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of ketotifen on human lymphocytes in vitro and in vivo.
    Petrasch S; van Tits LJ; Motulsky HJ; Brodde OE; Michel MC
    Arzneimittelforschung; 1993 Aug; 43(8):904-8. PubMed ID: 8216451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.